WuXi Biologics (Cayman) Inc. (2269.HK)

HKD 24.1

(5.7%)

Total Assets Summary of WuXi Biologics (Cayman) Inc.

WuXi Biologics (Cayman) Inc.'s latest annual total assets in 2023 was 56.57 Billion CNY , up 14.15% from previous year.
WuXi Biologics (Cayman) Inc.'s latest quarterly total assets in 2024 Q2 was 56.1 Billion CNY , down 0.0% from previous quarter.
WuXi Biologics (Cayman) Inc. reported annual total assets of 49.56 Billion CNY in 2022, up 12.56% from previous year.
WuXi Biologics (Cayman) Inc. reported annual total assets of 44.03 Billion CNY in 2021, up 52.03% from previous year.
WuXi Biologics (Cayman) Inc. reported quarterly total assets of 56.1 Billion CNY for 2024 Q1, down -0.83% from previous quarter.
WuXi Biologics (Cayman) Inc. reported quarterly total assets of 56.57 Billion CNY for 2023 FY, up 14.15% from previous quarter.

Annual Total Assets Chart of WuXi Biologics (Cayman) Inc. (2023 - 2014)

Historical Annual Total Assets of WuXi Biologics (Cayman) Inc. (2023 - 2014)

Year	Total Assets	Total Assets Growth
2023	56.57 Billion CNY	14.15%
2022	49.56 Billion CNY	12.56%
2021	44.03 Billion CNY	52.03%
2020	28.96 Billion CNY	64.54%
2019	17.6 Billion CNY	87.39%
2018	9.39 Billion CNY	93.71%
2017	4.84 Billion CNY	144.28%
2016	1.98 Billion CNY	46.31%
2015	1.35 Billion CNY	113.1%
2014	636.67 Million CNY	0.0%

Year	Total Assets	Total Assets Growth
2024 Q2	56.1 Billion CNY	0.0%
2024 Q1	56.1 Billion CNY	-0.83%
2023 FY	56.57 Billion CNY	14.15%
2023 Q3	56.57 Billion CNY	8.5%
2023 Q4	56.57 Billion CNY	0.0%
2023 Q2	52.14 Billion CNY	0.0%
2023 Q1	52.14 Billion CNY	5.2%
2022 Q3	49.56 Billion CNY	4.4%
2022 Q1	47.47 Billion CNY	7.81%
2022 FY	49.56 Billion CNY	12.56%
2022 Q4	49.56 Billion CNY	0.0%
2022 Q2	47.47 Billion CNY	0.0%
2021 Q3	44.03 Billion CNY	1.04%
2021 FY	44.03 Billion CNY	52.03%
2021 Q1	43.58 Billion CNY	50.47%
2021 Q4	44.03 Billion CNY	0.0%
2021 Q2	43.58 Billion CNY	0.0%
2020 Q4	28.96 Billion CNY	0.0%
2020 FY	28.96 Billion CNY	64.54%
2020 Q1	20.72 Billion CNY	17.73%
2020 Q2	20.72 Billion CNY	0.0%
2020 Q3	28.96 Billion CNY	39.76%
2019 FY	17.6 Billion CNY	87.39%
2019 Q4	17.6 Billion CNY	0.0%
2019 Q3	17.6 Billion CNY	72.43%
2019 Q2	10.2 Billion CNY	0.0%
2019 Q1	10.2 Billion CNY	8.68%
2018 Q1	8.57 Billion CNY	76.92%
2018 Q4	9.39 Billion CNY	0.0%
2018 Q3	9.39 Billion CNY	9.49%
2018 Q2	8.57 Billion CNY	0.0%
2018 FY	9.39 Billion CNY	93.71%
2017 Q1	5.63 Billion CNY	184.1%
2017 FY	4.84 Billion CNY	144.28%
2017 Q4	4.84 Billion CNY	0.0%
2017 Q3	4.84 Billion CNY	-14.01%
2017 Q2	5.63 Billion CNY	0.0%
2016 Q1	- CNY	-100.0%
2016 Q4	1.98 Billion CNY	0.0%
2016 FY	1.98 Billion CNY	46.31%
2015 Q4	1.35 Billion CNY	0.0%
2015 FY	1.35 Billion CNY	113.1%
2014 FY	636.67 Million CNY	0.0%

Peer Total Assets Comparison of WuXi Biologics (Cayman) Inc.

Name	Total Assets	Total Assets Difference
Uni-Bio Science Group Limited	409.99 Million HKD	-13699.227%
CK Life Sciences Int'l., (Holdings) Inc.	11.24 Billion HKD	-403.011%